Spectris (LON:SXS) had its price objective decreased by Morgan Stanley from GBX 2,850 ($37.24) to GBX 2,800 ($36.59) in a research note published on Wednesday morning. Morgan Stanley currently has an overweight rating on the stock.
SXS has been the subject of a number of other reports. Bank of America raised shares of Spectris to a buy rating in a research note on Monday, October 15th. Peel Hunt restated an add rating on shares of Spectris in a research report on Tuesday, November 20th. HSBC decreased their target price on shares of Spectris from GBX 2,750 ($35.93) to GBX 2,250 ($29.40) and set a hold rating on the stock in a research report on Tuesday, October 30th. BNP Paribas upgraded shares of Spectris to an outperform rating and raised their target price for the stock from GBX 2,550 ($33.32) to GBX 2,700 ($35.28) in a research report on Tuesday, September 18th. Finally, Shore Capital restated a hold rating on shares of Spectris in a research report on Tuesday, November 20th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and seven have given a buy rating to the company. The stock presently has a consensus rating of Hold and an average target price of GBX 2,749.23 ($35.92).
Shares of SXS opened at GBX 2,425 ($31.69) on Wednesday. Spectris has a 1-year low of GBX 2,225 ($29.07) and a 1-year high of GBX 2,869 ($37.49).
Spectris Company Profile
Spectris plc manufactures and sells measuring instruments and controls worldwide. It operates through four segments: Materials Analysis, Test and Measurement, In-line Instrumentation, and Industrial Controls. The Materials Analysis segment provides products and services, which enable customers to determine structure, composition, quantity, and quality of particles and materials during their research and development processes, when assessing materials before production, or during the manufacturing process.
Read More: Day Trading – Risk Worth the Reward?
Receive News & Ratings for Spectris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectris and related companies with MarketBeat.com's FREE daily email newsletter.